Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
LFCR Lifecore Biomedical
6.210-0.190-2.97%
Close
01/31 16:00 ET
6.2100.0000.00%
Post Mkt Price 01/31 16:01 ET
High
6.460
Open
6.390
Turnover
1.21M
Low
5.980
Pre Close
6.400
Volume
197.32K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Around $10M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the sto
Barrington Research Lowers Lifecore Biomedical (NASDAQ:LFCR) Price Target to $10.00
Lifecore Biomedical (NASDAQ:LFCR – Get Rating) had its target price cut by stock analysts at Barrington Research from $12.00 to $10.00 in a report released on Wednesday, The Fly reports. Barrington
Should You Hold Lifecore Biomedical (LFCR)?
Lifecore Biomedical Receives Non-Compliance Notice From Nasdaq
03:12 AM EST, 01/12/2023 (MT Newswires) -- Lifecore Biomedical (LFCR) said late Wednesday it received a notice from Nasdaq that the company is not in compliance with listing rules as it failed to time
Lifecore Biomedical Receives Notice From Nasdaq Regarding Delayed Quarterly Report
Lifecore Biomedical, Inc. ("Lifecore" or the "Company"), announced today that it received a notice ("Notice") on January 11, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market
Lifecore Discloses Nasdaq Listing Compliance Notice
Lifecore Price Target Lowered to $10 From $12 at Barrington
Press Release: Lifecore Biomedical Raises Capital With Private Placement of Convertible Preferred Stock; Amends Credit Facilities
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities $38.75 million Private Placement of Series A Convertible Preferred Stock to Support
4 Cheapest Defensive Stocks You Should Think About
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when price
Investors in Lifecore Biomedical (NASDAQ:LFCR) Have Unfortunately Lost 47% Over the Last Five Years
Company Overview
More
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. It operates through the following segments: Lifecore, Curation Foods, and Others. The Lifecore segment sells products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans. The Curation Foods segment includes activities to market and pack specialty packaged whole and fresh-cut fruit and vegetables. The Other segment consists of corporate general and administrative expenses, non-Curation Foods and non-Lifecore interest income, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Santa Maria, CA.
CEO： Mr. James G. Hall
Market： NASDAQ
Listing Date： 02/14/1996
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet